TNF Pharmaceuticals Shares Outstanding 2012-2024 | TNFA

TNF Pharmaceuticals shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.

TNF Pharmaceuticals Shares Outstanding 2012-2024 | TNFA

TNF Pharmaceuticals shares outstanding from 2012 to 2024. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Related Stocks
Company NameMarket
Cap
Zoetis (ZTS)$86.6B
Takeda Pharmaceutical (TAK)$46.8B
Merck (MKGAF)$24.9B
Summit Therapeutics (SMMT)$23.1B
Astellas Pharma (ALPMY)$21.7B
Sandoz Group AG (SDZNY)$17.9B
United Therapeutics (UTHR)$15.1B
Shionogi (SGIOY)$13.2B
Neurocrine Biosciences (NBIX)$12.3B
Catalent (CTLT)$10.8B
Orion OYJ (ORINY)$7.4B
Revolution Medicines (RVMD)$7.3B
Jazz Pharmaceuticals (JAZZ)$6.7B
Ionis Pharmaceuticals (IONS)$6.2B
Hikma Pharmaceuticals Plc (HKMPF)$5.7B
Madrigal Pharmaceuticals (MDGL)$5.3B
Crinetics Pharmaceuticals (CRNX)$4.3B
Corcept Therapeutics (CORT)$4B
Dyne Therapeutics (DYN)$3.4B
Arrowhead Pharmaceuticals (ARWR)$2.7B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.7B
PTC Therapeutics (PTCT)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.4B
Soleno Therapeutics (SLNO)$2.1B
Centessa Pharmaceuticals (CNTA)$1.9B
Recursion Pharmaceuticals (RXRX)$1.8B
BioCryst Pharmaceuticals (BCRX)$1.6B
Harrow (HROW)$1.6B
Ardelyx (ARDX)$1.5B
NewAmsterdam Pharma (NAMS)$1.4B